Skip to the page

Data / Form D filings / Prince Biotech, Inc.

Prince Biotech, Inc.: Form D filing

Prince Biotech, Inc., a biotechnology company in Mason, OH, filed a Form D with the SEC in 2025. The latest, on October 27, 2025, reports an offering of $10 million with nothing sold yet.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
5496 WINDING CAPE WAY, Mason, OH, 45040
Phone
(513) 378-0261
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2024
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2093745

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Oct 27, 2025New notice$10,000,000$0$10,000,0000Yet to occursec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Jay LevyExecutive Officer
Brian HuberExecutive Officer
Aaron PrinceExecutive Officer
Douglas PrinceExecutive Officer, Director
Steve SloateExecutive Officer

Other biotechnology companies in Ohio that filed recently

Every Form D from the week of Oct 27, 2025 · All recent filings in Ohio · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Prince Biotech, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.